RxDoctor Payments Data

Sheri Buckley

Family · Canton, GANPI 1073807855

Payments from drug & device makers

$1,306in general payments, 2019–2025

Across 52 payments — averaging $25.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$240
  • Amgen$194
  • Tandem Diabetes Care, Inc.$115
  • Mannkind Corporation$92
  • Sequel Med Tech, LLC$83
  • Lilly USA, LLC$76
  • plus $507 from 19 others

What the payments were for

  • Food & beverage$1,306100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,306 in reported general payments places this provider in the 70th percentile of 6,258 family providers in Georgia.

See all family providers in Georgia

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide32$45,642
OzempicSemaglutide21$31,301
Tresiba Flextouch U-200Insulin Degludec16$26,732
JanuviaSitagliptin Phosphate24$24,980
JardianceEmpagliflozin15$20,712
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog25$19,466
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog16$19,028
Soliqua 100-33Insulin Glargine/Lixisenatide14$18,621
Humalog Kwikpen U-100Insulin Lispro25$12,019
Lantus SolostarInsulin Glargine,hum.Rec.Anlog21$5,033
SynthroidLevothyroxine Sodium40$4,569
Nano 2nd Gen Pen NeedlePen Needle, Diabetic13$1,145
Unifine PentipsPen Needle, Diabetic13$422
Metformin Hcl43$420
Duloxetine Hcl11$250

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity$76$45,64232 claims
Novo NordiskOzempic$37$31,30121 claims
Boehringer IngelheimJardiance$13$20,71215 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$19$18,62114 claims
AbbVieSynthroid$12$4,56940 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 6,258 family providers in Georgia.

Other family in Canton

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →